Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Lappeenranta

4 clinical trials in Lappeenranta, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Lappeenranta at a glance
4
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Lappeenranta

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Vigabatrin
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-yhtymae

Ischaemic stroke

Not yet recruiting
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Lappeenranta

What the registry says about research in the country

01 Cardiovascular and Thrombosis Research

Innovative studies focusing on thromboprophylaxis in surgical patients, investigating preventive measures for blood clots during various surgical procedures. Research examines the effectiveness of oral factor Xa inhibitors combined with mechanical prevention methods.

  • Surgical Thrombosis Prevention
  • Anticoagulation Management
  • Post-operative Care

These trials aim to establish optimal protocols for preventing venous thromboembolism while managing bleeding risks.

02 Pediatric Neurology

Groundbreaking research in infantile spasm syndrome prevention, particularly focusing on high-risk infants under one year of age. Studies evaluate prophylactic treatments for children with tuberous sclerosis or vascular injuries.

  • Early Intervention Strategies
  • Neurological Prevention
  • Pediatric Brain Protection

Research targets preventive approaches for vulnerable infant populations with specific neurological risk factors.

03 Stroke Treatment Studies

Advanced clinical research exploring new therapeutic approaches for acute ischemic stroke treatment. Trials evaluate novel compounds like redasemtide to improve patient outcomes in stroke care.

  • Acute Stroke Intervention
  • Neuroprotective Therapies
  • Emergency Medicine

These studies aim to enhance treatment options and improve recovery prospects for stroke patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.